Avalo Therapeutics (AVTX) Amortization - Intangibles (2017 - 2022)

Avalo Therapeutics (AVTX) has 6 years of Amortization - Intangibles data on file, last reported at $38000.0 in Q1 2022.

• Quarterly Amortization - Intangibles fell 91.04% year-over-year to $38000.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $38000.0 (down 97.54% YoY) and the FY2022 annual result came in at $38000.0, down 97.55% from the prior year.
• Amortization - Intangibles fell to $38000.0 in Q1 2022, from $267000.0 in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $1.2 million in Q2 2018 to a low of -$1.5 million in Q4 2018.
• A 5-year average of $382032.1 and a median of $404000.0 in 2020 frame the typical range for Amortization - Intangibles.
• Annual changes were most pronounced in 2018 — Amortization - Intangibles slumped 468.58% — and 2019, when it soared 122.51%.
• Tracing AVTX's Amortization - Intangibles over 5 years: stood at -$1.5 million in 2018, then soared by 122.51% to $334753.0 in 2019, then soared by 50.26% to $503000.0 in 2020, then sank by 46.92% to $267000.0 in 2021, then slumped by 85.77% to $38000.0 in 2022.
• The last three Amortization - Intangibles figures came in at $38000.0 (Q1 2022), $267000.0 (Q4 2021), and $428000.0 (Q3 2021), per Business Quant data.